Progyny Business Model Canvas

Integration with insurers and TPAs streamlines eligibility, claims and care coordination, cutting administrative claim processing time by up to 30% and improving member access. Plans use Progyny to fill a fertility expertise gap as employer fertility benefit adoption reached about 60% in 2024. Product alignment supports carved-in or carved-out models, while joint analytics drive trend management and can reduce stop-loss variance by ~10%.

Progyny relies on large self-insured employers (60% employer fertility benefit adoption in 2024) and >100 credentialed clinics to deliver outcomes; multi-year contracts and tiered plans reduce per-cycle spend and enable data continuity. Insurer/TPA integrations cut claims processing ~30% and stop-loss variance ~10%. Specialty pharmacy and digital partners improve adherence and access.

Dedicated patient concierges guide members from intake to outcome, coordinating appointments, second opinions and treatment sequencing while addressing financial, emotional and clinical questions. Care navigation closes gaps with proactive outreach and reminders to reduce dropout. Infertility affects about 12% of US women, and CDC data show IVF live-birth rates for women under 35 around 53.6%, underscoring value of guided care.

Identify and credential 300+ clinics, enforce lab/protocol standards and negotiate success‑linked rates (US avg IVF cost ~$20,000/cycle in 2024; live‑birth ~53.6% <35).

Deliver concierge navigation, reduce dropouts, and sync specialty pharmacy (specialty drugs ~55% of drug spend) to target 10–15% drug savings.

Aggregate clinical/pharmacy/claims into an analytics lake with near‑real‑time dashboards and predictive models to optimize networks and cost‑per‑live‑birth.

Patient care advocates, nurses, and reproductive health experts guide members, translating clinical expertise into personalized care plans; multidisciplinary teams address both medical and psychosocial needs, building trust that increases engagement and adherence to treatment.

Progyny key resources: 1,000+ curated fertility clinics (2024) and national coverage enabling standardized care pathways. Integrated pharmacy links 1M+ prescriptions annually to outcomes and partners with 50+ specialty vendors and cold-chain logistics. Proprietary datasets, risk models, cloud-native analytics and employer/payer contracts (NASDAQ: PGNY) drive defensibility, predictable revenue and measurable ROI.

Progyny’s inclusive family-building coverage spans IVF, egg and embryo freezing, IUI, adoption, and surrogacy, explicitly supporting LGBTQ+ and single parents. Infertility affects about 1 in 8 US couples and assisted reproductive technology accounts for roughly 2% of US births (CDC). Policies are designed to align with employer DEI goals and tailored navigation respects member preferences and clinical and cultural needs.

Progyny delivers higher single-embryo transfer rates (72% in 2024), ~30% faster median time-to-pregnancy, and data-routing that raised per-cycle success ~18%, reducing complications and costs; integrated specialty pharmacy and precision coverage cut futile cycles and pharma waste; concierge navigation and top-quartile NPS strengthen member experience and employer ROI.

Clinical consultations and second opinions give members access to specialists, improving decision quality and changing treatment plans in roughly 30% of cases; Progyny’s standardized clinical reviews reduce overtreatment and unnecessary IVF cycles. Transparency in recommendations and clear documentation support trust and have been associated with up to 20% higher payer approval rates. Documentation also streamlines benefit approvals and appeals processes.

Dedicated account teams co-own employer goals with embedded clinical and financial KPIs; Progyny served >2,500 employer clients in 2024 and reports member satisfaction ~4.7/5. Personal advocates and digital channels reduce drop-off; clinical reviews change treatment plans in ~30% of cases and correlate with up to 20% higher payer approvals. Employer enablement accelerated rollouts amid 28% US employer fertility benefit penetration (2024).

Broker and consultant networks drive employer adoption of Progyny by influencing benefit design and vendor selection, with Progyny reporting service to over 700 employer clients in 2023, validating channel reach. Education programs and incentive structures increase broker recommendations, while thought leadership—white papers and outcomes data—elevates credibility among HR buyers. Strategic partnerships with major brokers shorten sales cycles and boost deal conversion rates.

Direct sales and RFPs secure multi-year contracts and served 700+ employer clients in 2023, providing predictable revenue. Health-plan co-brands reach ~155 million Americans (2023) and enable carved-in distribution. Brokers, thought leadership and digital channels boost enrollment; platform engagement rose 40% YoY (2024) and notifications cut delays ~25% in 2024 pilots.

Progyny augments health plan and TPA capabilities to reduce fertility-related medical trend by offering embedded programs or optional riders that integrate value analytics and high-quality provider networks. Plans benefit from actionable analytics and network quality metrics to control utilization and cost. Emphasis on operational ease minimizes admin burden for TPAs. By 2024 over 65% of large US employers offer fertility benefits, driving demand for turnkey solutions.

Large self-insured employers (≈67% of covered workers, KFF 2024) demand measurable ROI, national network access and DEI-aligned benefits. Mid-market (100–5,000 employees) want turnkey, predictable per-employee budgets and easy HRIS integration. Members seek navigation, affordability and tailored clinical pathways; IVF avg cost ≈ $22,000/cycle (2024).

People and operations at Progyny center on care advocates, clinicians, account managers, and support staff, driving labor and training costs as they managed care for over 1 million members by 2024. Ongoing training and quality assurance programs and a contact center handling roughly 100,000 annual interactions sustain service levels. Robust compliance and privacy management (HIPAA-focused) adds fixed governance and audit expenses.

Provider reimbursements and incentives are the largest clinical expense; medication acquisition is ~25–40% of per-patient spend with cold-chain adding 8–12%. People/ops and care coordination scale with 1M members managed by 2024. Cloud, integration and analytics drive recurring tech spend amid Gartner 2024 public cloud ~$597B. Sales commissions run 8–12% with RFP/implementation $50k–$200k per large account.

Progyny captures spread on fertility medications and dispensing fees, leveraging average US IVF medication costs of about $3,500 per cycle in 2024 to generate margin and per‑dispense revenue. Adherence programs reduce wasted cycles and boost net yield by improving medication compliance and outcomes. Higher client volumes secure better purchasing terms, while integrated dispensation cuts leakage and lowers unit costs across the care pathway.

PMPM/PEPM admin fees scale with covered lives, providing predictable monthly cash flow; case/bundle fees align payment to outcomes (median US IVF cost 2024: 20,000–25,000 per cycle). Medication spread (avg IVF meds 2024: ~3,500/cycle) and dispensing fees add margin. Performance incentives in 2024 pilots delivered 12–18% cost reduction; one-time implementation and analytics fees supplement revenue.